Glaukos Corp
A California eye-care company making tiny implants and dropless treatments for glaucoma and other eye conditions, its signature iStent is a micro-sized device placed in the eye to lower pressure. Founded in 1998, it pioneered micro-invasive glaucoma surgery with the first human implant of its stent in 2001. The name comes from ancient Greek "glaukos," meaning gleaming or blue-gray—the same root as the word "glaucoma."
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 13G/APassive | 9.2% | 5.35M | May 15, 2026 |
| Vanguard Portfolio Management | 13GPassive | 5.6% | 3.26M | Apr 29, 2026 |
| Vanguard Capital Management | 13GPassive | 5.07% | 2.95M | Apr 29, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 26, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 13GPassive | 5.88% | 3.38M | Feb 11, 2026 |
| Wellington Management Group LLP | 13G/APassive | 0.8% | 486.8K | Feb 10, 2026 |
| Wellington Group Holdings LLP | 13G/APassive | 0.8% | 486.8K | Feb 10, 2026 |
| Wellington Investment Advisors Holdings LLP | 13G/APassive | 0.8% | 486.8K | Feb 10, 2026 |
| FMR LLC | 13G/APassive | 4.5% | 2.56M | Aug 7, 2025 |
| Abigail P. Johnson | 13G/APassive | 4.5% | 2.56M | Aug 7, 2025 |